MedTrace Logo

Feasibility and Acceptability of Offering Self-sampling to Non-attendees in Primary Care

NCT02698423 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 667

Last updated 2018-06-06

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to determine whether human-papillomavirus (HPV) self-sampling can be used as a primary screening test for unscreened women.

Conditions

  • Cancer of the Uterine Cervix

Interventions

DEVICE

Cobas HPV DNA Test

Women will receive a home-sent sample for HPV self-testing

OTHER

Papanicolau test

Women will be invited to come in for a physician-performed Pap test

Sponsors & Collaborators

  • University Hospital, Geneva

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
SCREENING
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
25 Years
Max Age
69 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-09-30
Primary Completion
2016-01-31
Completion
2016-01-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02698423 on ClinicalTrials.gov